#52
Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
If you are a medical cannabis patient or considering becoming one, this research supports the clinical reality that responsible, guided cannabis use is not inherently dangerous, which may help normalize conversations with your other healthcare providers about incorporating cannabis into your treatment plan.
Canadian population-level data reinforces what clinicians who work with cannabis patients see daily: the vast majority of people who use cannabis do so without developing problematic use patterns. This finding is consistent with decades of research showing that cannabis use disorder affects a minority of users, typically estimated at 9-10% of those who try cannabis, and that medical cannabis patients under clinical guidance tend to have even lower rates of problematic use. Understanding this distinction between use and misuse is critical for shaping evidence-based policy and reducing the stigma that still prevents many patients from exploring cannabis as a therapeutic option.
“I have treated over 30,000 patients and the data matches my clinical experience perfectly: most people who use cannabis, especially under medical supervision, do so responsibly, and it is long past time we stop treating every cannabis patient like a future addiction case.”
? New Canadian population data shows what many of us in cannabis medicine have long observed: the vast majority of cannabis users do not develop problematic use patterns. In my clinic with over 30,000 patients, cannabis use disorder is the exception, not the rule, and it is typically manageable when identified early under proper medical supervision. The estimated rate of cannabis use disorder at around 9-10% of users is comparable to or lower than rates of problematic use seen with alcohol and many prescription medications we rarely question. Studies like this are essential because they dismantle the fear-based narratives that have kept cannabis out of mainstream medical conversations for decades. My hope is that data like this will encourage more clinicians to engage with cannabis medicine rather than reflexively dismissing it due to stigma.
Have thoughts on this? Share it:
? Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
